microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity.

Cell Cycle
Xue BaiBoxiong Ni

Abstract

Non-small cell lung cancer (NSCLC) is a leading cause of cancer death in both men and women. microRNAs (miRs) can exert important functions in cancer development. However, the role of miR-877 in NSCLC as it relates to tartrate resistant acid phosphatase 5 (ACP5) is unknown. For this study, the gain-and-loss-of-function experiments were performed to explore the effects of miR-877 and ACP5 on NSCLC. miR-877 expression in LC and paracancerous tissues, lung epithelial cell line and NSCLC cell lines was detected, and the association between miR-877 expression and clinical features of LC patients was analyzed. The levels of ACP5, epithelial-mesenchymal transition (EMT) markers and apoptosis-related proteins were measured. In vivo experiments were conducted for further validation. Consequently, we found that miR-877 expression was lowered in LC tissues and cell lines, and correlated with clinical stage, differentiation, lymph node metastasis and prognosis of NSCLC patients. Additionally, miR-877 was determined to inhibit ACP5 activity, and miR-877 downregulated the PI3K/AKT pathway by silencing ACP5. Furthermore, overexpression of miR-877 inhibited the viability, migration, invasion and EMT of NSCLC cells, but promoted cell apoptosis....Continue Reading

References

Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Zhan YaoRaffaella Sordella
May 23, 2012·JAMA : the Journal of the American Medical Association·Peter B BachFrank C Detterbeck
Jun 14, 2013·Biochemistry Research International·Yang KeRubo Cao
Aug 9, 2013·Nature Reviews. Cancer·Laís FajersztajnPaulo Saldiva
Dec 7, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jun ShenFeng Jiang
Aug 15, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ReckUNKNOWN ESMO Guidelines Working Group
Dec 17, 2015·Advances in Experimental Medicine and Biology·Lindsey A TorreAhmedin Jemal
Jul 13, 2016·Apoptosis : an International Journal on Programmed Cell Death·Ping XuXiaoyang He
Aug 28, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·María Torres-DuranAlberto Ruano-Ravina
Mar 18, 2017·Calcified Tissue International·Cecilia Halling LinderPer Magnusson
Apr 12, 2017·The Clinical Respiratory Journal·Ya-Li GaoXiao-Feng Tan

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
electrophoresis
Flow
flow cytometry
xenograft

Software Mentioned

OncoMir
miRWalk
TargetScan
SPSS

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis